标签归档：mem

Gibco含核苷的基础MEMα培养基(C12571500BT )

发表于由

上海金畔生物科技有限公司提供Gibco含核苷的基础MEMα培养基(C12571500BT ) ，欢迎访问官网了解更多产品信息和订购。
Gibco含核苷的基础MEMα培养基(C12571500BT )

Gibco含核苷的基础MEMα培养基广泛用于哺乳动物细胞培养以及转染 DHFR 阴性细胞的筛选。MEM α 可用于各种悬浮和贴壁的哺乳动物细胞，包括角质形成细胞、原代大鼠星形胶质细胞和人黑色素瘤细胞。针对广泛的细胞培养应用，提供了多种组分的 MEM α 改良培养基。

MEM α 是zui低必需培养基 (MEM) 的改良版本，其中包含非必需氨基酸、丙酮酸钠、硫辛酸、维生素 B12、生物素和抗坏血酸。MEM α 还提供不含核苷的版本，可用作 DG44 和其他 DHFR 阴性细胞的筛选培养基。该产品由 Earle’s 平衡盐制成。MEM α 不含蛋白质、脂质或生长因子。因此，MEM α 需要补充剂，通常添加 10% 胎牛血清 (FBS)。MEM α 使用碳酸氢钠缓冲系统 (2.2 g/L)，因此需要 5–10% CO2 环境来维持生理 pH 值。

产品属性：

细胞系：HeLa、BHK-21、293、HEP-2、HT-1080、MCF-7 和成纤维细胞

细胞类型：原代大鼠星形胶质细胞

分类：无动物来源

浓度：1 X

形式：液体

产品类型：MEM α（zui低必需培养基 α）

添加剂：低糖, 谷氨酰胺, 酚红, 丙酮酸钠, 核糖核苷, 脱氧核糖核苷

货号

产品名称

规格

C12571500BT

BASIC MEM α, Nucleosides

500 mL

 

Gibco Opti-MEM™ 减血清培养基

发表于由

上海金畔生物科技有限公司提供Gibco Opti-MEM™ 减血清培养基 ，欢迎访问官网了解更多产品信息和订购。
Gibco Opti-MEM™ 减血清培养基

详情介绍

Gibco Opti-MEM™ 减血清培养基

Gibco™ Opti-MEM™ is a unique media that contains insulin, transferrin, hypoxanthine, thymidine, and trace elements. These additional components allow for a reduction in serum supplementation by at least 50%.


cGMP Manufacturing and Quality System：

For supply chain continuity, we manufacture Gibco™ Opti-MEM™ at two separate facilities located in Grand Island, NY and Scotland, UK. Both sites are compliant with cGMP manufacturing requirements, are certified to ISO 13485, and are registered with the FDA as medical device manufacturers.


Gibco™ Opti-MEM™ uses a sodium bicarbonate buffer system (2.4 g/L) and therefore requires a 5-10% CO2 environment to maintain physiological pH.


Powder forms of Gibco™ cell culture medium require sodium bicarbonate supplementation, pH adjustment and filtration at the time of preparation

Gibco MEM Medium

发表于由

上海金畔生物科技有限公司提供Gibco MEM Medium ，欢迎访问官网了解更多产品信息和订购。
Gibco MEM Medium

详情介绍

Gibco MEM Medium

Using MEM：

MEM was developed by Harry Eagle, based on his earlier formulation of Basal Medium Eagle (BME). Many other modifications of MEM followed, including Glasgow’s MEM, MEM α, DMEM, and Temin’s Modification. MEM is available with Earle’s salts for use in a CO2 incubator, or with Hanks' salts for use without CO2. This product is made with Earle’s salts. MEM contains no proteins, lipids, or growth factors. Therefore, MEM requires supplementation, commonly with 10% Fetal Bovine Serum (FBS). MEM uses a sodium bicarbonate buffer system (2.2 g/L), and therefore requires a 5–10% CO2 environment to maintain physiological pH.


cGMP manufacturing and quality system：

MEM is manufactured at a cGMP-compliant facility located in Grand Island, New York. The facility is registered with the FDA as a medical device manufacturer and is certified to ISO 13485 standards. For supply chain continuity, we offer an identical MEM product made in our Scotland facility (31095-029). This facility is registered with the FDA as a medical device manufacturer and is certified to the ISO 13485 standard.

Opti-MEM™ I 减血清培养基 无酚红

发表于由

上海金畔生物科技有限公司提供Opti-MEM™ I 减血清培养基 无酚红 ，欢迎访问官网了解更多产品信息和订购。
Opti-MEM™ I 减血清培养基 无酚红

详情介绍

Opti-MEM™ I 减血清培养基 无酚红

Opti-MEM™ I medium can be used with a variety of suspension and adherent mammalian cells, including Sp2, AE-1, CHO, BHK-21, HEK, and primary fibroblasts.                                                                                                       Using Opti-MEM™ Reduced-Serum Medium：

Opti-MEM™ I medium is a unique medium that contains insulin, transferrin, hypoxanthine, thymidine, and trace elements. These additional components allow for a reduction in serum supplementation by at least 50%. Opti-MEM™ I medium uses a sodium bicarbonate buffer system (2.4 g/L), and therefore requires a 5–10% CO2 environment to maintain physiological pH.


cGMP manufacturing and quality system：

For supply chain continuity, we manufacture Opti-MEM™ Reduced-Serum Medium at two separate facilities located in Grand Island, NY and Scotland, UK. Both sites are compliant with cGMP manufacturing requirements, are certified to ISO 13485, and are registered with the FDA as medical device manufacturers.

Gibco™ MEM Rega-3

发表于由

上海金畔生物科技有限公司提供Gibco™ MEM Rega-3 ，欢迎访问官网了解更多产品信息和订购。
Gibco™ MEM Rega-3

详情介绍

Gibco™ MEM Rega-3

Gibco™ MEM, developed by Harry Eagle, was based on his earlier formulation of Basal Medium Eagle (BME). Many other modifications of MEM followed, including this Rega-3 modification. MEM Rega-3 is unique because it has a reduced sodium bicarbonate concentration, modified salt concentrations, and contains the antibiotic gentamycin sulfate. This product is made with Earle’s salts.


Product Use:

For Research Use Only: Not intended for animal or human diagnostic or therapeutic use.


cGMP Manufacturing and Quality System:

Gibco™ MEM is manufactured at a cGMP compliant facility located in Paisley, Scotland, UK. The facility is registered with the FDA as a medical device manufacturer and is certified to the ISO 13485 standard.


MEM Rega-3 contains no proteins, lipids, or growth factors. Therefore, MEM Rega-3 requires supplementation, commonly with 10% Fetal Bovine Serum (FBS). MEM uses a sodium bicarbonate buffer system (0.85 g ⁄ L) and therefore requires a low CO2 environment to maintain physiological pH.

Gibco™ Glasgow’s MEM培养基

发表于由

上海金畔生物科技有限公司提供Gibco™ Glasgow’s MEM培养基 ，欢迎访问官网了解更多产品信息和订购。
Gibco™ Glasgow’s MEM培养基

详情介绍

Gibco™ Glasgow's MEM培养基

Glasgow's MEM is unique from other media as it contains twice the concentration of amino acids and vitamins than the original Basal Medium Eagle, and is used without serum. Glasgow's MEM was originally formulated with 10% tryptose phosphate broth.


Dual-Site cGMP Manufacturing:

Gibco™ Glasgow's MEM is manufactured at a cGMP compliant facility, located in Paisley, Scotland, UK. The facility is registered with the FDA as a medical device manufacturer and is certified to the ISO 13485 standard. For supply chain continuity, we offer a comparable Gibco™ Glasgow's MEM product made in our Grand Island facility (11710-035). This facility is registered with the FDA as a medical device manufacturer and is certified to the ISO 13485 standards.


Glasgow's MEM contains no proteins, lipids, or growth factors. Therefore, Glasgow's MEM requires supplementation, commonly with 10% tryptose phosphate broth. Glasgow's MEM uses a sodium bicarbonate buffer system (2.75 g/L) and therefore requires a 5-10% CO2 environment to maintain physiological pH.

Gibco™CTS™ Opti-MEM™ I 培养基

发表于由

上海金畔生物科技有限公司提供Gibco™CTS™ Opti-MEM™ I 培养基 ，欢迎访问官网了解更多产品信息和订购。
Gibco™CTS™ Opti-MEM™ I 培养基

详情介绍

Gibco™CTS™ Opti-MEM™ I 培养基

CTS Opti-MEM I uses a sodium bicarbonate buffer system (2.4 g/L), and therefore requires a 5–10% CO2 environment to maintain physiological pH. The formulation of CTS Opti-MEM I is identical to research-grade Opti-MEM I Reduced Serum Medium.


CTS Opti-MEM I is xeno-free and contains human transferrin.


CTS Opti-MEM I is manufactured in conformity with cGMP for medical devices, 21 CFR, Part 820, and certified to the ISO 13485. Drug Master File and Regulatory Support File available upon request.


Custom configuration and packaging available upon request.

Gibco MEM,Hanks平衡盐

发表于由

上海金畔生物科技有限公司提供Gibco MEM,Hanks平衡盐 ，欢迎访问官网了解更多产品信息和订购。
Gibco MEM,Hanks平衡盐

详情介绍

Gibco MEM,Hanks平衡盐

Dual-Site cGMP Manufacturing：

Gibco™ MEM is manufactured at a cGMP compliant facility, located in Paisley, Scotland, UK. The facility is registered with the FDA as a medical device manufacturer and is certified to the ISO 13485 standard. For supply chain continuity, we offer an identical Gibco™ MEM product made in our Grand Island facility (11575-032). This facility is registered with the FDA as a medical device manufacturer and is certified to the ISO 13485 standards.


MEM contains no proteins, lipids, or growth factors. Therefore, MEM requires supplementation, commonly with 10% Fetal Bovine Serum (FBS). This MEM formulation does not require a CO2 environment to maintain physiological pH.

Gibco MEM培养基, NEAA, no glutamine

发表于由

上海金畔生物科技有限公司提供Gibco MEM培养基, NEAA, no glutamine ，欢迎访问官网了解更多产品信息和订购。
Gibco MEM培养基, NEAA, no glutamine

详情介绍

Gibco™ MEM, NEAA, no glutamine

Gibco™ MEM, developed by Harry Eagle, was based on his earlier formulation of Basal Medium Eagle (BME). Many other modifications of MEM followed, including Glasgow's MEM, MEM α, DMEM, and Temin's Modification. MEM is available with Earle's salts for use in a CO2 incubator, or with Hanks' salts for use without CO2. This product is made with Earle's salts.


Dual-Site cGMP Manufacturing：

Gibco™ MEM is manufactured at a cGMP compliant facility, located in Grand Island, New York. The facility is registered with the FDA as a medical device manufacturer and is certified to ISO 13485 standards. For supply chain continuity, we offer an identical Gibco™ MEM product made in our Scotland facility (10370-021). This facility is registered with the FDA as a medical device manufacturer and is certified to the ISO 13485 standard.


MEM contains no proteins, lipids, or growth factors. Therefore, MEM requires supplementation, commonly with 10% Fetal Bovine Serum (FBS). MEM uses a sodium bicarbonate buffer system (2.2 g/L) and therefore requires a 5–10% CO2 environment to maintain physiological pH.

Gibco MEM培养基，含HEPES

发表于由

上海金畔生物科技有限公司提供Gibco MEM培养基，含HEPES ，欢迎访问官网了解更多产品信息和订购。
Gibco MEM培养基，含HEPES

详情介绍

Gibco MEM培养基，含HEPES

Gibco™ MEM, developed by Harry Eagle, was based on his earlier formulation of Basal Medium Eagle (BME). Many other modifications of MEM followed, including Glasgow’s MEM, MEM α, DMEM, and Temin’s Modification. MEM is available with Earle’s salts for use in a CO2 incubator, or with Hanks' salts for use without CO2. This product is made with Earle’s salts.


cGMP Manufacturing and Quality System:

Gibco™ MEM is manufactured at a cGMP compliant facility, located in Paisley, Scotland, UK. The facility is registered with the FDA as a medical device manufacturer and is certified to the ISO 13485 standard. For supply chain continuity, we offer an identical Gibco™ MEM product made in our Grand Island facility (12360-038). This facility is registered with the FDA as a medical device manufacturer and is certified to the ISO 13485 standards.


MEM contains no proteins, lipids, or growth factors. Therefore, MEM requires supplementation, commonly with 10% Fetal Bovine Serum (FBS). MEM uses a sodium bicarbonate buffer system (2.2 g/L) and therefore requires a 5–10% CO2 environment to maintain physiological pH.

Gibco MEM干粉培养基, 含HEPES现货

发表于由

上海金畔生物科技有限公司提供Gibco MEM干粉培养基, 含HEPES现货 ，欢迎访问官网了解更多产品信息和订购。
Gibco MEM干粉培养基, 含HEPES现货

详情介绍

Gibco MEM干粉培养基, 含HEPES现货

Gibco™ MEM, developed by Harry Eagle, was based on his earlier formulation of Basal Medium Eagle (BME). Many other modifications of MEM followed, including Glasgow’s MEM, MEM α, DMEM, and Temin’s Modification. MEM is available with Earle’s salts for use in a CO2 incubator, or with Hanks' salts for use without CO2. This product is made with Earle’s salts.


Product Use:

For Research Use Only: Not intended for animal or human diagnostic or therapeutic use.


cGMP Manufacturing and Quality System:

Gibco™ MEM is manufactured at a cGMP compliant facility, located in Paisley, Scotland, UK. The facility is registered with the FDA as a medical device manufacturer and is certified to the ISO 13485 standard.


Powder forms of Gibco™ L-15 cell culture medium require pH adjustment and filtration at the time of preparation.

Gibco™ MEM, no glutamine

发表于由

上海金畔生物科技有限公司提供Gibco™ MEM, no glutamine ，欢迎访问官网了解更多产品信息和订购。
Gibco™ MEM, no glutamine

详情介绍

Gibco™ MEM, no glutamine

Gibco™ MEM, developed by Harry Eagle, was based on his earlier formulation of Basal Medium Eagle (BME). Many other modifications of MEM followed, including Glasgow’s MEM, MEM α, DMEM, and Temin’s Modification. MEM is available with Earle’s salts for use in a CO2 incubator, or with Hanks' salts for use without CO2. This product is made with Earle’s salts.


cGMP Manufacturing and Quality System:

Gibco™ MEM is manufactured at a cGMP compliant facility, located in Paisley, Scotland, UK. The facility is registered with the FDA as a medical device manufacturer and is certified to the ISO 13485 standard. For supply chain continuity, we offer an identical Gibco™ MEM product made in our Grand Island facility (11090-081). This facility is registered with the FDA as a medical device manufacturer and is certified to the ISO 13485 standards.


MEM contains no proteins, lipids, or growth factors. Therefore, MEM requires supplementation, commonly with 10% Fetal Bovine Serum (FBS). MEM uses a sodium bicarbonate buffer system (2.2 g/L) and therefore requires a 5–10% CO2 environment to maintain physiological pH.

Gibco™ Opti-MEM™ I Reduced Serum Medium, GlutaMAX™

发表于由

上海金畔生物科技有限公司提供Gibco™ Opti-MEM™ I Reduced Serum Medium, GlutaMAX™ ，欢迎访问官网了解更多产品信息和订购。
Gibco™ Opti-MEM™ I Reduced Serum Medium, GlutaMAX™

详情介绍

Gibco™ Opti-MEM™ I Reduced Serum Medium, GlutaMAX™ Supplement

Opti-MEM™ I medium can be used with a variety of suspension and adherent mammalian cells, including Sp2, AE-1, CHO, BHK-21, HEK, and primary fibroblasts.                                                                                                      Using Opti-MEM™ I Medium：

Opti-MEM™ I Reduced-Serum Medium is a unique medium that contains insulin, transferrin, hypoxanthine, thymidine, and trace elements. These additional components allow for a reduction in serum supplementation by at least 50%. Opti-MEM™ I medium uses a sodium bicarbonate buffer system (2.4 g/L), and therefore requires a 5–10% CO2 environment to maintain physiological pH.


cGMP manufacturing and quality system：

Opti-MEM™ I is manufactured at a cGMP-compliant facility located in Grand Island, New York. The facility is registered with the FDA as a medical device manufacturer and is certified to ISO 13485 standards. For supply chain continuity, we offer an identical Opti-MEM™ I product made in our Scotland facility (51985-042). This facility is also registered with the FDA as a medical device manufacturer and certified to the ISO 13485 standard.

Gibco™ MEM, HEPES, no glutamine

发表于由

上海金畔生物科技有限公司提供Gibco™ MEM, HEPES, no glutamine ，欢迎访问官网了解更多产品信息和订购。
Gibco™ MEM, HEPES, no glutamine

详情介绍

Gibco™ MEM, HEPES, no glutamine

Minimum Essential Medium (MEM) is one of the most commonly used of all cell culture media. MEM can be used with a variety of suspension and adherent mammalian cells, including HeLa, BHK-21, 293, HEP-2, HT-1080, MCF-7, fibroblasts, and primary rat astrocytes. We offer a variety of Gibco™ MEM modifications for a range of cell culture applications. Find the right formulation using the media selector tool.

This MEM is modified as follows:

With Without

• HEPES • L-glutamine

• Phenol Red 


The complete formulation is available.


Gibco™ MEM, developed by Harry Eagle, was based on his earlier formulation of Basal Medium Eagle (BME). Many other modifications of MEM followed, including Glasgow’s MEM, MEM α, DMEM, and Temin’s Modification. MEM is available with Earle’s salts for use in a CO2 incubator, or with Hanks' salts for use without CO2. This product is made with Earle’s salts.


cGMP Manufacturing and Quality System：

Gibco™ MEM is manufactured at a cGMP compliant facility, located in Grand Island, New York. The facility is registered with the FDA as a medical device manufacturer and is certified to ISO 13485 standards. For supply chain continuity, we offer an identical Gibco™ MEM product made in our Scotland facility (32360-026). This facility is registered with the FDA as a medical device manufacturer and is certified to the ISO 13485 standard.


MEM contains no proteins, lipids, or growth factors. Therefore, MEM requires supplementation, commonly with 10% Fetal Bovine Serum (FBS). MEM uses a sodium bicarbonate buffer system (2.2 g/L) and therefore requires a 5–10% CO2 environment to maintain physiological pH.

Gibco MEM培养基，无酚红

发表于由

上海金畔生物科技有限公司提供Gibco MEM培养基，无酚红 ，欢迎访问官网了解更多产品信息和订购。
Gibco MEM培养基，无酚红

详情介绍

Gibco MEM培养基，无酚红

Gibco™ Richter’s MEM is a modified formulation of Eagle's MEM that contains iron, zinc, putrescine, fatty acids, and gentamycin. Richter’s modification also includes very high concentrations of both choline chloride and i-Inositol. This product is made with Earle’s salts.


Product Use：

For Research Use Only: Not intended for animal or human diagnostic or therapeutic use.


cGMP Manufacturing：

Gibco™ MEM is manufactured at a cGMP compliant facility located in Grand Island, New York. The facility is registered with the FDA as a medical device manufacturer and is certified to ISO 13485 standards.


Gibco™ MEM contains no proteins, lipids, or growth factors. Therefore, MEM requires supplementation, commonly with 10% Fetal Bovine Serum (FBS). MEM uses a sodium bicarbonate buffer system (2.2 g/L) and therefore requires a 5-10% CO2 environment to maintain physiological pH.


Gibco MEM α培养基

发表于由

上海金畔生物科技有限公司提供Gibco MEM α培养基 ，欢迎访问官网了解更多产品信息和订购。
Gibco MEM α培养基

详情介绍

Gibco MEM α培养基

Using MEM α：

MEM α is a modification of Minimum Essential Medium (MEM) that contains non-essential amino acids, sodium pyruvate, lipoic acid, vitamin B12, biotin, and ascorbic acid. MEM α is available without nucleosides for use as a selection medium for DG44 and other DHFR-negative cells. This MEM is modified without ascorbic acid. MEM α contains no proteins, lipids, or growth factors. Therefore, MEM α requires supplementation, commonly with 10% Fetal Bovine Serum (FBS). MEM α uses a sodium bicarbonate buffer system (2.2 g/L), and therefore requires a 5–10% CO2 environment to maintain physiological pH.


cGMP manufacturing and quality system：

MEM α is manufactured at a cGMP-compliant facility located in Grand Island, New York. The facility is registered with the FDA as a medical device manufacturer and is certified to ISO 13485 standards.


Gibco™ MEM (Richter’s modification), no phenol red

发表于由

上海金畔生物科技有限公司提供Gibco™ MEM (Richter’s modification), no phenol red ，欢迎访问官网了解更多产品信息和订购。
Gibco™ MEM (Richter’s modification), no phenol red

详情介绍

Gibco™ MEM (Richter's modification), no phenol red, no gentamycin

Gibco™ Richter's MEM is a modified formulation of Eagle's MEM that contains iron, zinc, putrescine, fatty acids, and gentamycin. Richter's modification also includes very high concentrations of both choline chloride and i-Inositol. This product was further modified with L-glutamine, without gentamicin sulfate, and without phenol red.


Product Use：

For Research Use Only. Not for use in diagnostic procedures.


Dual-Site cGMP Manufacturing：

Gibco™ Richter's MEM is manufactured at a cGMP compliant facility, located in Grand Island, New York. The facility is registered with the FDA as a medical device manufacturer and is certified to ISO 13485 standards.


Gibco™ MEM contains no proteins, lipids, or growth factors. Therefore, MEM requires supplementation, commonly with 10% Fetal Bovine Serum (FBS). MEM uses a sodium bicarbonate buffer system (2.2 g/L) and therefore requires a 5-10% CO2 environment to maintain physiological pH.


Gibco™ Opti-MEM™ Reduced Serum Medium, powder

发表于由

上海金畔生物科技有限公司提供Gibco™ Opti-MEM™ Reduced Serum Medium, powder ，欢迎访问官网了解更多产品信息和订购。
Gibco™ Opti-MEM™ Reduced Serum Medium, powder

详情介绍

Gibco™ Opti-MEM™ Reduced Serum Medium, powder

Gibco™ Opti-MEM™ is a unique media that contains insulin, transferrin, hypoxanthine, thymidine, and trace elements. These additional components allow for a reduction in serum supplementation by at least 50%.


cGMP Manufacturing and Quality System：

For supply chain continuity, we manufacture Gibco™ Opti-MEM™ at two separate facilities located in Grand Island, NY and Scotland, UK. Both sites are compliant with cGMP manufacturing requirements, are certified to ISO 13485, and are registered with the FDA as medical device manufacturers.


Gibco™ Opti-MEM™ uses a sodium bicarbonate buffer system (2.4 g/L) and therefore requires a 5-10% CO2 environment to maintain physiological pH.


Powder forms of Gibco™ cell culture medium require sodium bicarbonate supplementation, pH adjustment and filtration at the time of preparation


Gibco™ MEM, Hanks’ Balanced Salts

发表于由

上海金畔生物科技有限公司提供Gibco™ MEM, Hanks’ Balanced Salts ，欢迎访问官网了解更多产品信息和订购。
Gibco™ MEM, Hanks’ Balanced Salts

详情介绍

Gibco™ MEM, Hanks' Balanced Salts

Gibco™ MEM, developed by Harry Eagle, was based on his earlier formulation of Basal Medium Eagle (BME). Many other modifications of MEM followed, including Glasgow's MEM, MEM α, DMEM, and Temin's Modification. This MEM formulation contains Hanks' salts for use without CO2.


Dual-Site cGMP Manufacturing：

Gibco™ MEM is manufactured at a cGMP compliant facility, located in Grand Island, New York. The facility is registered with the FDA as a medical device manufacturer and is certified to ISO 13485 standards. For supply chain continuity, we offer an identical Gibco™ MEM product made in our Scotland facility (21575-022). This facility is registered with the FDA as a medical device manufacturer and is certified to the ISO 13485 standard.


MEM contains no proteins, lipids, or growth factors. Therefore, MEM requires supplementation, commonly with 10% Fetal Bovine Serum (FBS). This MEM formulation does not require a CO2 environment to maintain physiological pH.


Gibco™ MEM

发表于由

上海金畔生物科技有限公司提供Gibco™ MEM ，欢迎访问官网了解更多产品信息和订购。
Gibco™ MEM

详情介绍

Gibco™ MEM

Using MEM：

MEM was developed by Harry Eagle, based on his earlier formulation of Basal Medium Eagle (BME). Many other modifications of MEM followed, including Glasgow’s MEM, MEM α, DMEM, and Temin’s Modification. MEM is available with Earle’s salts for use in a CO2 incubator, or with Hanks' salts for use without CO2. This product is made with Earle’s salts. MEM contains no proteins, lipids, or growth factors. Therefore, MEM requires supplementation, commonly with 10% Fetal Bovine Serum (FBS). MEM uses a sodium bicarbonate buffer system (2.2 g/L), and therefore requires a 5–10% CO2 environment to maintain physiological pH.


cGMP manufacturing and quality system：

MEM is manufactured at a cGMP-compliant facility located in Grand Island, New York. The facility is registered with the FDA as a medical device manufacturer and is certified to ISO 13485 standards. For supply chain continuity, we offer an identical MEM product made in our Scotland facility (31095-029). This facility is registered with the FDA as a medical device manufacturer and is certified to the ISO 13485 standard.